2 results
8-K
EX-99.1
GLYC
GlycoMimetics Inc
1 Mar 24
Regulation FD Disclosure
9:16am
=66 Relapsed/Refractory Patient Demographics Age, median (range) 58 (20-75) 59 (26-84) Refractory, n (%) 129 (33%) 22 (33%) Relapsed, n (%) 259 (67%) 44
8-K
EX-99.1
GLYC
GlycoMimetics Inc
3 Aug 22
GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2022
8:25am
with relapsed/refractory acute myeloid leukemia (AML)
Progress in data collection now enables the Company to share a comparison of the demographics … /refractory AML. Progress to date now enables the Company to share a comparison of the demographics of those 388 patients against the patient
- Prev
- 1
- Next